Cal-101
Showing 26 - 50 of 875
Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)
Recruiting
- Community-acquired Pneumonia
- Bacterial Pneumonia
- CMTX-101
- Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Jan 20, 2023
Gingivitis Trial in Cambridge (AMY-101, Water for injection)
Completed
- Gingivitis
- AMY-101
- Water for injection
-
Cambridge, MassachusettsForsyth Institute
Feb 19, 2021
Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, RDEB Trial in Redwood City, Worcester (EB-101 Surgical
Not yet recruiting
- Epidermolysis Bullosa
- +2 more
- EB-101 Surgical application of RDEB wounds
-
Redwood City, California
- +1 more
Feb 13, 2023
NSCLC, HNSCC, Melanoma Trial (CJRB-101, Pembrolizumab injection)
Not yet recruiting
- NSCLC
- +5 more
- CJRB-101
- Pembrolizumab injection
- (no location specified)
Jun 1, 2023
Idiopathic Inflammatory Myopathies, Diffuse Cutaneous Systemic Sclerosis, SLE Nephritis Trial (KYV-101, Cyclophosphamide,
Not yet recruiting
- Idiopathic Inflammatory Myopathies
- +3 more
- KYV-101
- +2 more
- (no location specified)
Nov 21, 2023
Orthostatic Hypotension Trial in Newcastle Upon Tyne (ISO-101)
Not yet recruiting
- Orthostatic Hypotension
- ISO-101
-
Newcastle Upon Tyne, United KingdomFalls and Syncope Service, Older People's Medicine, The Newcastl
Sep 8, 2023
Oropharyngeal Squamous Cell Carcinoma Trial in Saint Louis (CUE-101)
Recruiting
- Oropharyngeal Squamous Cell Carcinoma
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
Pulmonary Arterial Hypertension Trial in Indianapolis (AV-101)
Recruiting
- Pulmonary Arterial Hypertension
-
Indianapolis, IndianaIndiana University Health
Dec 6, 2022
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Atezolizumab
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jul 6, 2023
HIV-1-infection Trial in San Francisco, Saint Louis, Camden (EBT-101)
Enrolling by invitation
- HIV-1-infection
- EBT-101
-
San Francisco, California
- +2 more
Oct 17, 2022
Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)
Recruiting
- Age-Related Macular Degeneration
- VOY-101
-
Sydney, New South Wales, Australia
- +3 more
Oct 17, 2023
Effectiveness, and Safety ofFixed-dose Combination of
Not yet recruiting
- Plaque Psoriasis
- CAL/BDP PAD Cream
- (no location specified)
Mar 31, 2023
Diabetes, Type 2 Trial in Pasadena (Financial support for healthy foods and free home delivery, Free home delivery)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Financial support for healthy foods and free home delivery
- Free home delivery
-
Pasadena, CaliforniaKaiser Permanente Southern California Department of Research & E
Sep 25, 2023
Alpha 1-Antitrypsin Deficiency, Emphysema Trial (INBRX-101)
Not yet recruiting
- Alpha 1-Antitrypsin Deficiency
- Emphysema
- (no location specified)
May 31, 2023
Glucocorticoids Toxicity, COVID-19, Infectious Disease Trial in Bangalore (101-PGC-005)
Active, not recruiting
- Glucocorticoids Toxicity
- +3 more
-
Bangalore, Karnataka, IndiaICBio Clinical Research Pvt. Ltd.
Dec 13, 2022
Celiac Disease, Coeliac Disease Trial (KAN-101, Placebo)
Not yet recruiting
- Celiac Disease
- Coeliac Disease
- KAN-101
- Placebo
- (no location specified)
Aug 14, 2023
QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)
Recruiting
- QT/QTc
- Ecopipam Hydrochloride
- +2 more
-
Austin, TexasPPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023
Healthy Volunteers Trial in Cincinnati (VEL-101, Placebo)
Recruiting
- Healthy Volunteers
- VEL-101
- Placebo
-
Cincinnati, OhioCTI Clinical Research Center
Nov 1, 2022
Healthy People Trial in Pomona (Grape Powder)
Not yet recruiting
- Healthy People
- Grape Powder
-
Pomona, CaliforniaCal Poly Pomona
Aug 20, 2023
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Jul 14, 2023
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Nonalcoholic Steatohepatitis Trial in Israel (5 mg/kg CM-101, Placebo)
Completed
- Nonalcoholic Steatohepatitis
- 5 mg/kg CM-101
- Placebo
-
Be'er Sheva, Israel
- +8 more
Apr 11, 2023